未登录

W

Will Dampier

drexel university

H指数:21

被引数:2,617

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Inflammatory microglia signals drive A1-like polarization of astrocytes even in the presence of HIV-1 Tat

炎症小胶质细胞信号即使在HIV-1 Tat存在的情况下也能驱动星形胶质细胞的A1样极化

Molecular Neurobiology

IF4.3

2025-12-040

OAAI

Evaluating classic (TLR4) and novel (dopaminergic) mediated inflammatory responses in human macrophages across distinct culture and serum supplementation conditions

JOURNAL OF IMMUNOLOGY

IF3.4

2025-11-010

PRE

Microenvironmental conditions and serum availability alter primary human macrophage NF-κB inflammatory response and function

Channer, B.; Daniali, M.; Sheldon, L.; Emanuel, K.; Agarwal, Y.; Kist, T.; Murphy, B.J.; Niu, M.; Dampier, W.; Fox, H.; et al. 微环境条件及血清可及性改变原代人类巨噬细胞的NF-κB炎症反应和功能。Vet. Med. Int. 2025, 117, qiaf071. [Google Scholar] [CrossRef]

JOURNAL OF LEUKOCYTE BIOLOGY

IF3.1

2025-07-010

OA

Evaluating Dopamine-Driven Inflammatory Responses in Human Macrophages and the Effects of Culture Media and Serum Availability

评估多巴胺驱动的炎症反应在人类巨噬细胞中的表现及培养基和血清可用性的影响

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2025-03-010

PRE

Delivering CRISPR to the HIV-1 reservoirs

FRONTIERS IN MICROBIOLOGY

IF4.5

2024-05-151

OAAI

Immunomodulatory Effects of Non-Thermal Plasma in a Model for Latent HIV-1 Infection: Implications for an HIV-1-Specific Immunotherapy

IF3.9

2023-01-033

OAAI

Examining virtual driving test performance and its relationship to individuals with HIV-associated neurocognitive disorders

FRONTIERS IN NEUROSCIENCE

IF3.2

2022-08-242

OAAI

HIV-1 cure strategies: why CRISPR?

EXPERT OPINION ON BIOLOGICAL THERAPY

IF4

2021-02-0722

OA

Commentary to Gusenbauer and Haddaway 2020: Evaluating retrieval qualities of Google Scholar and PubMed

RESEARCH SYNTHESIS METHODS

IF6.1

2020-10-085

OAAI

Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites

MOLECULAR THERAPY-NUCLEIC ACIDS

IF0

2020-09-0115

OAAI

Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing

FRONTIERS IN MICROBIOLOGY

IF4.5

2020-08-1214

OAAI

HIV-1 Tat Length: Comparative and Functional Considerations

HIV-1 Tat长度: 比较和功能考虑

FRONTIERS IN MICROBIOLOGY

IF4.5

2020-03-2417

OAAI

Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency

MOLECULAR THERAPY

IF12

2020-01-0125

OAAI

Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patients

SCIENTIFIC REPORTS

IF3.9

2019-11-1929

OAAI

Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection

FRONTIERS IN MICROBIOLOGY

IF4.5

2018-12-1759

OAAI

Prediction of Human Immunodeficiency Virus Type 1 Subtype-Specific Off-Target Effects Arising from CRISPR-Cas9 Gene Editing Therapy

IF4

2018-08-0112

OAAI

GOATOOLS: A Python library for Gene Ontology analyses

GOATOOLS: 用于基因本体论分析的Python库

SCIENTIFIC REPORTS

IF3.9

2018-07-18748

OAAI

Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants

SCIENTIFIC REPORTS

IF3.9

2017-10-3134

OAAI

Large-scale integration of microarray data reveals genes and pathways common to multiple cancer types

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2011-04-1144

OAAI

Attenuation of Forkhead signaling by the retinal determination factor DACH1

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2010-03-2956

OAAI